TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
02/12/2025
Voltar para busca
Dado oficial do USPTO
CRYOXPAND
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: MistaEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
33
Atualização mais recente
04/12/2025
Classificação
Registrada
Tipo de marca
Mista
Classes Nice
11, 40
Data de depósito
10/11/2021
Data de registro
03/10/2023
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
03/10/2023
Última transação
04/12/2025
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
3
Tipo de titular
99
Localização do titular
ES
Examinador
RUSKIN,MATTHEW SEAN
Unidade examinadora
L60
Localização atual
PUBLICATION AND ISSUE SECTION
Descrição da marca
The mark consists of the wording cryoxpand in capital stylized letters. The letter X is in a scale of green and has one dot in each angle and two dots at the end of each line of the letter. The rest of the letters are in black. The background is transparent and is not claimed as a feature of the mark.
Titulares e representantes
Titulares
SITEC PHARMABIO, S.L.
Representantes
Elizabeth Lee D'Amore Lucas & Mercanti LLP
Classificação técnica
Classes Nice
Classe 11Classe 40
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 11
Apparatus for chemical treatmentheat exchangers for chemical processing; industrial treatment installationsapparatus for the transformation of fluid materials into micronized powders via rapid cooling through controlled spraying of the fluid material through a nozzle and simultaneous exposure of the sprayed fluid to a flow of expanding liquid-dense carbon dioxidecontained in a spraying tower; cooling appliances and devices and installationscooling evaporator to freeze sprayed fluid material during evaporation of liquid expanding carbon dioxide; cryogenic freezers and vaporizersin particular machines and apparatus for the crystallisation or solidification in amorphous form of substances for chemicalpharmaceuticalfood or cosmetic purposesin particular apparatus for conveying and atomising a mixture of coldliquefied or dense gas and a substancefluid or mixture containing gasenabling solidification in micronised powder form; drying apparatus and installationsdrying apparatus for chemical processing; freeze drying equipment in the nature of apparatus and devices for removing water and drying substances at low temperature to obtain the resultant substance in micronised powder form
Classe 40
Processing of chemicals; machining parts for othersin relation to pharmaceuticals; processing of nutraceuticals; processing of chemicals for use in the production of microparticle and nanoparticle powder systems; processing of pharmaceuticals for use in the production of microparticle and nanoparticle powder systems; processing of neutraceuticals for use in the production of microparticle and nanoparticle powder systems; treatment of chemicalstransformation of chemicalsnamely processing of fluids into solidmicronized powderstransformation of liquids into solid particles; processing and transformation of pharmaceuticals for otherscustom manufacture of pharmaceutical ingredients; treatment and transforming being custom manufacture of pharmaceutical molecules and formulations; treatment and transforming being custom manufacture of nutritional supplements; treatment and transforming of plants and medicinal herbs in the nature of distilling chemicals for others; treatment and transforming of polymeric materials in the nature of custom manufacture of polymers for chemicalpharmaceuticalfoodcosmetic uses; treatment and transforming being custom manufacture of oils and fats for fine chemicalpharmaceuticalfoodcosmetic uses; modification of particlescustom production of micronized powders to be used in solid dosage formsin liquid forms or in semisolid formscomposed of particles with specific properties of flowabilitydispersibility in aqueous or oily mediaof solubility; custom production of powder preparations for the pharmaceuticalfood and chemical industries; custom manufacture of microparticles and nanoparticles for chemicalpharmaceuticalfoodcosmetic uses; custom manufacture being custom manufacture of pharmaceuticals and medicines containing microparticles and nanoparticles; custom manufacture of nano-particle devices and microparticle devices for chemicalpharmaceuticalfoodcosmetic uses
Publicações
Histórico de despachos e eventos da marca no USPTO.
33 publicações encontradas
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
02/12/2025
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
02/12/2025
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
02/12/2025
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
30/01/2024
FICS
FINAL DISPOSITION NOTICE SENT TO IB
05/01/2024
FIMP
FINAL DISPOSITION PROCESSED
05/01/2024
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
03/01/2024
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
03/10/2023
R.PR
REGISTERED-PRINCIPAL REGISTER
03/10/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
18/07/2023
PUBO
PUBLISHED FOR OPPOSITION
18/07/2023
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
10/07/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
28/06/2023
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
21/06/2023
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
20/06/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
08/06/2023
XAEC
EXAMINER'S AMENDMENT ENTERED
08/06/2023
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
08/06/2023
GNEA
EXAMINERS AMENDMENT E-MAILED
08/06/2023
CNEA
EXAMINERS AMENDMENT -WRITTEN
08/06/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
01/05/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
01/05/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
01/05/2023
RFNP
REFUSAL PROCESSED BY IB
21/11/2022
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
02/11/2022
RFRR
REFUSAL PROCESSED BY MPU
01/11/2022
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
03/09/2022
CNRT
NON-FINAL ACTION WRITTEN
02/09/2022
DOCK
ASSIGNED TO EXAMINER
22/08/2022
MAFR
APPLICATION FILING RECEIPT MAILED
26/01/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
22/01/2022
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
20/01/2022
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace CRYOXPAND ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.